Data as of Jan 30
| +0.23 / +0.34%|
The 4 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 78.00, with a high estimate of 96.40 and a low estimate of 65.00. The median estimate represents a +14.47% increase from the last price of 68.14.
The current consensus among 4 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.